KEYBIO-TENTAMUS Wins „Invest in Provence“ Award and Announces Ambitious Growth Plans

It is with great pride that KEYBIO, a member of the TENTAMUS group, has been honored with the prestigious "Invest in Provence" award, recognizing its commitment and contribution to the regional economic development.

During the ceremony, Jérémy LENS, representing KEYBIO on behalf of TENTAMUS, expressed their gratitude: "We would like to extend our sincere thanks to Thomas Wolf for his unwavering trust, and to Provence Promotion – the Invest in Provence agency – for this partnership, which strengthens our shared ambition of developing a dynamic and forward-thinking ecosystem."

A 30-year Journey of Expertise in Microbiology

KEYBIO’s story began in a small 140 m² laboratory in Aubagne, surrounded by the Garlaban and Sainte-Baume mountains. Today, the company operates out of a modern 2,000 m² facility in La Ciotat, with a stunning view over the bay. With over 30 years of expertise, KEYBIO has become a leading reference in microbiology, particularly in the fields of medical devices, pharmaceuticals, cosmetics, and biocides.

Strategic Partnership with Tentamus to Reach New Heights

The acquisition of KEYBIO by the TENTAMUS group in 2024 marked a significant milestone in the company’s history. Founded in 2011, Tentamus is a global group with more than 4,000 employees across 97 locations in 22 countries. "This partnership with Tentamus, whose values and vision align closely with ours, allows us to take our growth to the next level. Together, we are building an ambitious strategy: to become the leading player in microbiological risk management for medical devices in France." said Jérémy LENS.

Impressive Financial Results and Ambitious Growth Targets

KEYBIO’s growth is reflected in strong financial and operational performance:

  • In just three years, revenue has surged by 40%, reaching €5.3 million by the end of 2024.
  • The company aims to hit €11 million in revenue by 2027.

On the human resources side, KEYBIO plans to expand its workforce from the current 45 employees to 70 by 2027, with 25 new hires planned, primarily lab technicians.

A Promising Recognition for the Future

This award highlights the remarkable progress made and the exciting future ahead for KEYBIO as the company continues to contribute to the development of the Provence region while tackling new challenges.

About KEYBIO

KEYBIO is a microbiology company specializing in medical devices, pharmaceuticals, cosmetics, and biocides. With more than 30 years of expertise, KEYBIO is a trusted leader in microbiological risk management.

KEYBIO
539 avenue du Mistral
13600 LA CIOTAT, France
keybio@keybio.com

More information:
https://www.tentamus.com

Follow us on social media:
https://www.linkedin.com/company/tentamus-group/
https://www.instagram.com/tentamus/

Über die Tentamus Group GmbH

Founded in 2011, Tentamus Group is a global organization specializing in quality assurance and risk management across the health, food safety, and environmental sectors, with offices in 22 countries.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com

Ansprechpartner:
Sara Pinto
Telefon: +49 (30) 206038403
E-Mail: sara.pinto@tentamus.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel